# A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine (0462-087)

> **NCT00894556** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 109 (actual)

## Conditions studied

- Acute Migraine

## Interventions

- **DRUG:** rizatriptan
- **DRUG:** Comparator: Placebo
- **DRUG:** Comparator: Sumatriptan

## Key facts

- **NCT ID:** NCT00894556
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06-10
- **Primary completion:** 2010-01-12
- **Final completion:** 2010-01-12
- **Target enrollment:** 109 (ACTUAL)
- **Last updated:** 2024-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00894556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00894556, "A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine (0462-087)". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00894556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*